191 related articles for article (PubMed ID: 21468443)
21. Downregulation of survivin expression and enhanced chemosensitivity of MCF-7 cells to adriamycin by PDMAE/survivin shRNA complex nanoparticles.
Yang Y; Gao Y; Chen L; Huang Y; Li Y
Int J Pharm; 2011 Feb; 405(1-2):188-95. PubMed ID: 21130850
[TBL] [Abstract][Full Text] [Related]
22. Transport of polymeric nanoparticle gene carriers in gastric mucus.
Dawson M; Krauland E; Wirtz D; Hanes J
Biotechnol Prog; 2004; 20(3):851-7. PubMed ID: 15176891
[TBL] [Abstract][Full Text] [Related]
23. Cyclodextrin-based supramolecular architectures: syntheses, structures, and applications for drug and gene delivery.
Li J; Loh XJ
Adv Drug Deliv Rev; 2008 Jun; 60(9):1000-17. PubMed ID: 18413280
[TBL] [Abstract][Full Text] [Related]
24. Co-delivery of doxorubicin and plasmid by a novel FGFR-mediated cationic liposome.
Xiao W; Chen X; Yang L; Mao Y; Wei Y; Chen L
Int J Pharm; 2010 Jun; 393(1-2):119-26. PubMed ID: 20416367
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and characterization of polyrotaxanes consisting of cationic alpha-cyclodextrins threaded on poly[(ethylene oxide)-ran-(propylene oxide)] as gene carriers.
Yang C; Wang X; Li H; Goh SH; Li J
Biomacromolecules; 2007 Nov; 8(11):3365-74. PubMed ID: 17929967
[TBL] [Abstract][Full Text] [Related]
26. Poly(D,L-lactide-co-glycolide acid) nanoparticles for DNA delivery: waiving preparation complexity and increasing efficiency.
Gvili K; Benny O; Danino D; Machluf M
Biopolymers; 2007 Apr 5-15; 85(5-6):379-91. PubMed ID: 17266128
[TBL] [Abstract][Full Text] [Related]
27. Efficient delivery of Bcl-2-targeted siRNA using cationic polymer nanoparticles: downregulating mRNA expression level and sensitizing cancer cells to anticancer drug.
Beh CW; Seow WY; Wang Y; Zhang Y; Ong ZY; Ee PL; Yang YY
Biomacromolecules; 2009 Jan; 10(1):41-8. PubMed ID: 19072631
[TBL] [Abstract][Full Text] [Related]
28. Ultrapure chitosan oligomers as carriers for corneal gene transfer.
Klausner EA; Zhang Z; Chapman RL; Multack RF; Volin MV
Biomaterials; 2010 Mar; 31(7):1814-20. PubMed ID: 19879644
[TBL] [Abstract][Full Text] [Related]
29. Polymeric nanoparticles of cholesterol-modified glycol chitosan for doxorubicin delivery: preparation and in-vitro and in-vivo characterization.
Yu JM; Li YJ; Qiu LY; Jin Y
J Pharm Pharmacol; 2009 Jun; 61(6):713-9. PubMed ID: 19505361
[TBL] [Abstract][Full Text] [Related]
30. Intracellularly Degradable, Self-Assembled Amphiphilic Block Copolycurcumin Nanoparticles for Efficient In Vivo Cancer Chemotherapy.
Lv L; Guo Y; Shen Y; Liu J; Zhang W; Zhou D; Guo S
Adv Healthc Mater; 2015 Jul; 4(10):1496-501, 1423. PubMed ID: 26033838
[TBL] [Abstract][Full Text] [Related]
31. A supramolecular approach to the preparation of charge-tunable dendritic polycations for efficient gene delivery.
Dong R; Zhou L; Wu J; Tu C; Su Y; Zhu B; Gu H; Yan D; Zhu X
Chem Commun (Camb); 2011 May; 47(19):5473-5. PubMed ID: 21483915
[TBL] [Abstract][Full Text] [Related]
32. Degradable poly(beta-amino ester) nanoparticles for cancer cytoplasmic drug delivery.
Shen Y; Tang H; Zhan Y; Van Kirk EA; Murdoch WJ
Nanomedicine; 2009 Jun; 5(2):192-201. PubMed ID: 19223244
[TBL] [Abstract][Full Text] [Related]
33. Self-assembly of amphiphilic tripeptides into nanoparticles for drug delivery.
Tu Z; Xu X; Jian Y; Zhong D; He B; Gu Z
Protein Pept Lett; 2014; 21(2):194-9. PubMed ID: 24188026
[TBL] [Abstract][Full Text] [Related]
34. Self-assembled nanoparticles based on hydrophobically modified chitosan as carriers for doxorubicin.
Zhang J; Chen XG; Li YY; Liu CS
Nanomedicine; 2007 Dec; 3(4):258-65. PubMed ID: 17962086
[TBL] [Abstract][Full Text] [Related]
35. Simultaneous delivery of doxorubicin and GG918 (Elacridar) by new polymer-lipid hybrid nanoparticles (PLN) for enhanced treatment of multidrug-resistant breast cancer.
Wong HL; Bendayan R; Rauth AM; Wu XY
J Control Release; 2006 Dec; 116(3):275-84. PubMed ID: 17097178
[TBL] [Abstract][Full Text] [Related]
36. Coordination bonding based pH-responsive albumin nanoparticles for anticancer drug delivery.
Li C; Xing L; Che S
Dalton Trans; 2012 Apr; 41(13):3714-9. PubMed ID: 22370556
[TBL] [Abstract][Full Text] [Related]
37. Folate-mediated poly(3-hydroxybutyrate-co-3-hydroxyoctanoate) nanoparticles for targeting drug delivery.
Zhang C; Zhao L; Dong Y; Zhang X; Lin J; Chen Z
Eur J Pharm Biopharm; 2010 Sep; 76(1):10-6. PubMed ID: 20472060
[TBL] [Abstract][Full Text] [Related]
38. Photochemical internalization for pDNA transfection: evaluation of poly(d,l-lactide-co-glycolide) and poly(ethylenimine) nanoparticles.
Gargouri M; Sapin A; Arıca-Yegin B; Merlin JL; Becuwe P; Maincent P
Int J Pharm; 2011 Jan; 403(1-2):276-84. PubMed ID: 21044878
[TBL] [Abstract][Full Text] [Related]
39. A library of aminoglycoside-derived lipopolymer nanoparticles for delivery of small molecules and nucleic acids.
Godeshala S; Miryala B; Dutta S; Christensen MD; Nandi P; Chiu PL; Rege K
J Mater Chem B; 2020 Sep; 8(37):8558-8572. PubMed ID: 32830211
[TBL] [Abstract][Full Text] [Related]
40. Development of pH-responsive core-shell nanocarriers for delivery of therapeutic and diagnostic agents.
Xu S; Luo Y; Graeser R; Warnecke A; Kratz F; Hauff P; Licha K; Haag R
Bioorg Med Chem Lett; 2009 Feb; 19(3):1030-4. PubMed ID: 19097889
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
